[ad_1]
Entry 2020.11.18 11:06
Daily sales of Sinoparm and Sinobac vaccines in hours
Zhejiang provincial government buys vaccines and sells them directly to residents
Even companies that receive between 10 and 20 times the price of the vaccine and make vaccination reservations
Concerned for Medical Professionals … Possibility of Late Side Effects
People are lining up in China to buy corona vaccine candidates, which have yet to complete clinical trials. Although the safety and effectiveness were not proven, the demand was overwhelming, and even specialized dealers appeared that sold more than 20 times the price of the vaccine.
Sinopharm is selling out of its Beijing headquarters, and Sinobag currently sells vaccination sites at various locations in Zhejiang, China, for 400 yuan (67,000 won). Jiaxing City of Zhejiang Province, Yiwu City, Ningbo City, and Shaoxing City have partnered with pharmaceutical companies to inoculate vaccines for high-risk groups, such as workers in medical institutions or employees of state-owned companies that they plan to travel abroad soon. And it will be extended to the general public.
According to the NYT, recently in Yiwu, daily sales for hundreds of people to get vaccinations ended in hours. Other cities are beginning to limit the amount of vaccine a person can receive and to ask for proof that they will soon be traveling abroad.
Vendors even showed up who made reservations for the vaccine. They receive between $ 600 and $ 1,500 (660,000 won to 1.66 million won), which is 10 to 20 times the price of the vaccine, but it is not known which route they use. One of the providers only told NYT that “we are working with Sinovac.”
The fact that phase 3 clinical trials are ongoing means that the efficacy and safety of the vaccine have not been 100% proven. A participant in a phase 3 clinical trial conducted by Sinovac in Brazil committed suicide last month, and the trial was suspended and resumed. The cause of the suicide remains unknown, but the São Paulo state government has concluded that it has nothing to do with the synovac vaccine.
However, the Chinese are lining up to say that the vaccine was applied by politicians and senior executives, saying it shows its effectiveness. China said it would distribute the vaccine to employees of state-owned companies, bureaucrats and company executives who have to go abroad, but it is known that it has not strictly restricted what others are right.
Some Chinese are patriots because China began to vaccinate the corona vaccine that countries around the world are developing. Wang Mingtao, a Chinese man in his 40s who works for a gold mining company in Ghana, posted a video of people lining up to buy vaccines at the Sinoparm headquarters in Beijing on the Chinese version of TikTok, writing: “Our country is strong”.
He paid $ 150 to buy a vaccine made by the Sinoparm subsidiary, and on the same day they gave him an injection in each arm. Vaccine experts explain that vaccines that require two doses should be given 14 to 28 days apart. Wang Mingtao said, “Since our country said this vaccine is fine, I think it would be better to just get it.”
Medical experts are concerned about China’s premature vaccination. People who have received a vaccine that is still in testing can become overly relieved and violate quarantine guidelines, and when a vaccine is released with proven safety and efficacy, it can be subordinated to vaccination. There are no side effects at this time, but there is a possibility that it will be confirmed later.
For decades, China’s vaccine scandals have caused ripples in the medical community. In 2018, vaccine maker Changchun Changseong Biotechnology was investigated for making a rabies vaccine for children by manipulating research data. In 2017, it was discovered that the Wuhan Institute of Biologicals created a diphtheria vaccine that was not effective.
The Chinese government is using the corona vaccine as a means of easing concerns about vaccines made in China. Pharmaceutical companies are actively expanding sales so they can secure profits before having to control both prices and quantities when official sales become available after the phase 3 clinical trial is successfully completed, US public radio NPR said. .
To date, it is not known how many people have been vaccinated. Sinopharm Chairman and Chinese Communist Party Secretary Liu Jing-jeon said last week: “To date, the company has vaccinated 100,000 people, of whom 56,000 have gone abroad after vaccination, and no one has been infected with the crown. ” The results of the phase 3 clinical trial are expected to be published later this month.
